Company Filing History:
Years Active: 2005
Title: Innovator Spotlight: Greg Hardee and His Pioneering Patent
Introduction: Greg Hardee, an inventive mind based in Rancho Santa Fe, California, has made significant contributions to the field of biotechnology. Known for his innovative approach to enhancing the delivery of oligonucleotides, Hardee has secured one patent that underscores his commitment to advancing medical science.
Latest Patents: Hardee's most notable patent, titled "Compositions and methods for the delivery of oligonucleotides via the alimentary canal," focuses on improving the transport of nucleic acids across the mucosal barriers in the alimentary canal of animals. His invention proposes methods and compositions that utilize a combination of penetration enhancers such as fatty acids, bile salts, and chelating agents. These agents are designed to boost the stability and transport of nucleic acids, facilitating the oral delivery of antisense oligonucleotides. The ultimate goal of this innovation is to modulate gene expression for therapeutic, investigative, or prophylactic purposes.
Career Highlights: Currently, Greg Hardee is associated with Isis Pharmaceuticals, Inc., a prominent player in the biotechnology field. His role at the company has allowed him to develop and refine his ideas, leading to impactful innovations that may transform the way certain diseases are treated through genetic modulation.
Collaborations: During his career, Hardee has had the opportunity to collaborate with talented professionals, including his coworker Ching-Leou Teng. These collaborations not only enhance the creative process but also lead to the amalgamation of diverse expertise that is critical in the realm of scientific research and development.
Conclusion: Greg Hardee exemplifies the spirit of innovation in biotechnology. With his patent focused on the efficient delivery of oligonucleotides, he stands at the forefront of advancements in genetic therapy. His work at Isis Pharmaceuticals, Inc., along with strategic collaborations, continues to pave the way for groundbreaking developments that have the potential to greatly benefit medical science and patient care.